Literature DB >> 31660018

Glycemic Control During Gender-Affirming Therapy in a Patient With Type 1 Diabetes.

Sarah H Campbell1, Kristen L Flint2, J Sonya Haw2, Georgia M Davis2, Priyathama Vellanki2.   

Abstract

Entities:  

Year:  2019        PMID： 31660018      PMCID： PMC6794227          DOI： 10.2337/cd19-0016

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN： 0891-8929


× No keyword cloud information.
  20 in total

1.  Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.

Authors:  D Kapoor; E Goodwin; K S Channer; T H Jones
Journal:  Eur J Endocrinol       Date:  2006-06       Impact factor: 6.664

2.  Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.

Authors:  Nelly Pitteloud; Megan Hardin; Andrew A Dwyer; Elena Valassi; Maria Yialamas; Dariush Elahi; Frances J Hayes
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

Review 3.  Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women.

Authors:  S R Salpeter; J M E Walsh; T M Ormiston; E Greyber; N S Buckley; E E Salpeter
Journal:  Diabetes Obes Metab       Date:  2006-09       Impact factor: 6.577

4.  Early Hormonal Treatment Affects Body Composition and Body Shape in Young Transgender Adolescents.

Authors:  Maartje Klaver; Renée de Mutsert; Chantal M Wiepjes; Jos W R Twisk; Martin den Heijer; Joost Rotteveel; Daniël T Klink
Journal:  J Sex Med       Date:  2018-02       Impact factor: 3.802

5.  Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.

Authors:  Wylie C Hembree; Peggy T Cohen-Kettenis; Louis Gooren; Sabine E Hannema; Walter J Meyer; M Hassan Murad; Stephen M Rosenthal; Joshua D Safer; Vin Tangpricha; Guy G T'Sjoen
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

6.  Pre-diabetes and serum sex steroid hormones among US men.

Authors:  R Arthur; S Rohrmann; H Møller; E Selvin; A S Dobs; N Kanarek; W Nelson; E A Platz; M Van Hemelrijck
Journal:  Andrology       Date:  2016-10-28       Impact factor: 3.842

Review 7.  Combined estrogen replacement therapy on metabolic control in postmenopausal women with diabetes mellitus.

Authors:  Youhua Xu; Jing Lin; Shanshan Wang; Jianfeng Xiong; Quan Zhu
Journal:  Kaohsiung J Med Sci       Date:  2014-04-18       Impact factor: 2.744

8.  The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women.

Authors:  C Walton; I F Godsland; A J Proudler; V Wynn; J C Stevenson
Journal:  Eur J Clin Invest       Date:  1993-08       Impact factor: 4.686

9.  Induction of insulin resistance by androgens and estrogens.

Authors:  K H Polderman; L J Gooren; H Asscheman; A Bakker; R J Heine
Journal:  J Clin Endocrinol Metab       Date:  1994-07       Impact factor: 5.958

10.  Sex hormone-binding globulin and risk of type 2 diabetes in women and men.

Authors:  Eric L Ding; Yiqing Song; JoAnn E Manson; David J Hunter; Cathy C Lee; Nader Rifai; Julie E Buring; J Michael Gaziano; Simin Liu
Journal:  N Engl J Med       Date:  2009-08-05       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.